Transgenic restoration of long-chain n-3 fatty acids in insulin target tissues improves resolution capacity and alleviates obesity-linked inflammation and insulin resistance in high-fat-fed mice
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The catabasis of inflammation is an active process directed by n-3 derived pro-resolving lipid mediators. We aimed to determine whether high-fat (HF) diet-induced n-3 deficiency compromises the resolution capacity of obese mice and thereby contributes to obesity-linked inflammation and insulin resistance. RESEARCH DESIGN AND METHODS: We used transgenic expression of the fat-1 n-3 fatty acid desaturase from C. elegans to endogenously restore n-3 fatty acids in HF-fed mice. After 8 weeks on HF or chow diets, wild-type and fat-1 transgenic mice were subjected to insulin and glucose tolerance tests and a resolution assay was performed. Metabolic tissues were then harvested for biochemical analyses. RESULTS: We report that the n-3 docosanoid resolution mediator protectin D1 is lacking in muscle and adipose tissue of HF-fed wild-type mice. Accordingly, HF-fed wild-type mice have an impaired capacity to resolve an acute inflammatory response and display elevated adipose macrophage accrual and chemokine/cytokine expression. This is associated with insulin resistance and higher activation of iNOS and JNK in muscle and liver. These defects are reversed in HF-fed fat-1 mice, in which the biosynthesis of this important n-3 docosanoid resolution mediator is improved. Importantly, transgenic restoration of n-3 fatty acids prevented obesity-linked inflammation and insulin resistance in HF-fed mice without altering food intake, weight gain, or adiposity. CONCLUSIONS: We conclude that inefficient biosynthesis of n-3 resolution mediators in muscle and adipose tissue contributes to the maintenance of chronic inflammation in obesity and that these novel lipids offer exciting potential for the treatment of insulin resistance and diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![FIG. 1. HF feeding reduces n-3 availability for resolution mediator synthesis. A: 8 weeks of HF feeding raised but fat-1 (F1) transgenesis restored the long-chain n-6:n-3 ratio in membrane phospholipids of muscle, liver, and epididymal adipose tissue. C, standard laboratory chow; AA, arachidonic acid (20:4 n-6); EPA, eicosapentaenoic acid (20:5 n-3); DPA, docosapentaenoic acid (22:5 n-3); DHA, docosahexaenoic acid (22:6 n-3). Data are mean ± SEM (n = 3). **P < 0.01 versus WTC; ***P < 0.001 versus WTC; †P < 0.05 versus WTHF; ††P < 0.01 versus WTHF. B: Comparison of n-3 docosanoid and eicosanoid biosynthetic pathways by LC-MS/MS in muscle, liver, and epididymal adipose tissue of HF-fed mice revealed that the docosanoid biosynthetic pathway has greater flux in metabolic tissues. Above left schematic diagram of docosanoid biosynthetic pathway showing the biosynthetic marker 17-HDoHE and PD1 (10R,17S-dihydroxydocosa-4Z,7Z,11E,13E,15Z,19Z-hexaenoic acid [28]) as well as the immediate PD1 precursor 17-HpDoHE. At right, the eicosanoid pathway showing 18-HEPE and RvE1 (5S,12R,18R-trihydroxy-6Z,8E,10E,14Z,16E-EPA [29]). ND indicates not detected. Data are mean ± SEM (n = 9–14). *P < 0.05, **P < 0.01, ***P < 0.001 versus 17-HDoHE. C: Representative LC-MS/MS spectra for 17-HDoHE, PD1, and 18-HEPE; retention times were 22.6, 18.2, and 20.6 min, respectively. D: Comparison of n-3 docosanoid and eicosanoid biosynthetic pathway activity by LC-MS/MS in muscle, liver, and epididymal adipose tissue of HF-fed wild-type and F1 mice reveals increased levels of docosanoid resolution mediator synthesis in muscle and adipose tissue of F1 mice compared with wild-type mice. Data are mean ± SEM (n = 6–10). *P < 0.05 versus WTHF. (A high-quality color representation of this figure is available in the online issue.)](https://figures.cochat.ai/paper-figures/30ad9df130664140a877cc8cc6a3d230/transgenic-restoration-of-long-chain-n-3-fatty-acids-in-insulin-target-tissues-figure-1.jpg)



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Fat-1 mice were also protected from obesity related inflammatory activity and decrements in insulin sensitivity [47].”
From Omega-3 Fatty Acids and Skeletal Muscle Health (2015) · cites this paper as [47]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041
Inflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199 · cited 2×
“Furthermore, it is critical to determine whether n-3 lipid mediators regulate key obesity-related inflammatory reactions such as macrophage accrual in adipose tissue or activation of inflammatory signaling molecules such as JNK and iNOS that play a role in the etiology of insulin resistance (1,2).”
BackgroundXu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., Sole, J., Nichols, A., Ross, J. S., Tartaglia, L. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319451 · Cited by 6,760 · cited 1×
“HF-fed obese mice exhibited an impaired capacity to resolve an acute inflammatory response to TNF and showed abundant macrophage infiltration in adipose tissue that was linked to heightened chemokine and cytokine expression, a hallmark of obesity-linked inflammation (18,19).”
BackgroundMutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
A central role for JNK in obesity and insulin resistance
Hirosumi, J., Tuncman, G., Chang, L., Görgün, C. Z., Uysal, K. T., Maeda, K., Karin, M., & Hotamisligil, G. S. (2002) · Nature · doi:10.1038/nature01137 · Cited by 3,359 · cited 11×
“Our data further suggest that restoring long-chain n-3 PUFAs also prevents obesity-linked insulin resistance by blunting lipid-induced JNK and iNOS activation in muscle and liver.”
BackgroundInfluentialKim, H. J., Park, S. Y., Choi, Y. J., Han, S. J., Lee, K. W., & Kim, D. J. (2013) · Hormone Research in Paediatrics · doi:10.1159/000348848 · Cited by 3,048
Cinti, S., Mitchell, G., Barbatelli, G., Murano, I., Ceresi, E., Faloia, E., Wang, S., Fortier, M., Greenberg, A. S., & Obin, M. S. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m500294-jlr200 · Cited by 2,529
Lipid mediator class switching during acute inflammation: signals in resolution
Levy, B. D., Clish, C. B., Schmidt, B., Gronert, K., & Serhan, C. N. (2001) · Nature Immunology · doi:10.1038/89759 · Cited by 1,453 · cited 1×
“To test this, we subjected mice to a dorsal air-pouch TNF challenge, an established model of self-resolving inflammation (13).”
MethodResolvin E1 and protectin D1 activate inflammation-resolution programmes
Schwab, J. M., Chiang, N., Arita, M., & Serhan, C. N. (2007) · Nature · doi:10.1038/nature05877 · Cited by 1,184
Self-citationSerhan, C. N. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141647 · Cited by 997
Arita, M., Bianchini, F., Aliberti, J., Sher, A., Chiang, N., Hong, S., Yang, R., Petasis, N. A., & Serhan, C. N. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042031 · Cited by 922
Self-citationMaresins: Novel macrophage mediators with potent antiinflammatory and proresolving actions
Serhan, C. N., Yang, R., Martinod, K., Kasuga, K., Pillai, P. S., Porter, T. F., Oh, S. F., & Spite, M. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20081880 · Cited by 908 · cited 1×
“This anti-inflammatory effect in liver may be the result of reduced inflammatory crosstalk from adipose tissue with fewer recruited macrophages or may represent the local actions of another class of bioactive n-3 metabolite such as the newly discovered maresins (22) or EFOX (23), which should be the focus of future in…”
BackgroundGonzález-Périz, A., Horrillo, R., Ferré, N., Gronert, K., Dong, B., Morán-Salvador, E., Titos, E., Martínez-Clemente, M., López-Parra, M., Arroyo, V., et al. (2009) · The FASEB Journal · doi:10.1096/fj.08-125674 · Cited by 555
Fat-1 mice convert n-6 to n-3 fatty acids
Kang, J. X., Wang, J., Wu, L., & Kang, Z. B. (2004) · Nature · doi:10.1038/427504a · Cited by 545
Self-citationPerreault, M., & Marette, A. (2001) · Nature Medicine · doi:10.1038/nm1001-1138 · Cited by 539
Self-citationSerhan, C. N., Gotlinger, K., Hong, S., Lu, Y., Siegelman, J., Baer, T., Yang, R., Colgan, S. P., & Petasis, N. A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.3.1848 · Cited by 455
Endogenous pro‐resolving and anti‐inflammatory lipid mediators: a new pharmacologic genus
Serhan, C. N., & Chiang, N. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707489 · Cited by 431
Ruzickova, J., Rossmeisl, M., Prazak, T., Flachs, P., Sponarova, J., Vecka, M., Tvrzicka, E., Bryhn, M., & Kopecky, J. (2004) · Lipids · doi:10.1007/s11745-004-1345-9 · Cited by 327
Cyclooxygenase-2 generates anti-inflammatory mediators from omega-3 fatty acids
Groeger, A. L., Cipollina, C., Cole, M. P., Woodcock, S. R., Bonacci, G., Rudolph, T. K., Rudolph, V., Freeman, B. A., & Schopfer, F. J. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.367 · Cited by 295
Dietary Omega-3 Fatty Acid Intake and Cardiovascular Risk
Psota, T. L., Gebauer, S. K., & Kris-Etherton, P. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.12.022 · Cited by 268
Anti‐obesity effects of long‐chain omega‐3 polyunsaturated fatty acids
Buckley, J. D., & Howe, P. R. C. (2009) · Obesity Reviews · doi:10.1111/j.1467-789x.2009.00584.x · Cited by 213
Gingras, A., White, P. J., Chouinard, P. Y., Julien, P., Davis, T. A., Dombrowski, L., Couture, Y., Dubreuil, P., Myre, A., Bergeron, K., et al. (2007) · The Journal of Physiology · doi:10.1113/jphysiol.2006.121079 · Cited by 193 · cited 1×
“Fatty acid composition of phospholipid fractions was analyzed by gas chromatography as per ref (12).”
MethodSelf-citationEvolutionary Aspects of Diet and Essential Fatty Acids
Simopoulos, A. P. (2000) · KARGER eBooks · doi:10.1159/000059742 · Cited by 173
Browning, L. M., Krebs, J. D., Moore, C. S., Mishra, G. D., O’Connell, M. A., & Jebb, S. A. (2007) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2006.00576.x · Cited by 162
Contrasting effects of fish oil and safflower oil on hepatic peroxisomal and tissue lipid content
Neschen, S., Moore, I., Regittnig, W., Yu, C. L., Wang, Y., Pypaert, M., Petersen, K. F., & Shulman, G. I. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00414.2001 · Cited by 156
Ebbesson, S. O. E., Risica, P. M., Ebbesson, L. O. E., Kennish, J. M., & Tejero, M. E. (2005) · International Journal of Circumpolar Health · doi:10.3402/ijch.v64i4.18016 · Cited by 120
Dopamine Selectively Induces Migration and Homing of Naive CD8+ T Cells via Dopamine Receptor D3
Watanabe, Y., Nakayama, T., Nagakubo, D., Hieshima, K., Jin, Z., Katou, F., Hashimoto, K., & Yoshie, O. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.2.848 · Cited by 110
Significance of the N‐6/N‐3 Ratio for Insulin Action in Diabetes
Raheja, B. S., SADIKOT, S. M., Phatak, R. B., & RAO, M. B. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb35715.x · Cited by 93
Dallaire, P., Bellmann, K., Laplante, M., Gélinas, S., Centeno-Baez, C., Penfornis, P., Peyot, M.-L., Latour, M. G., Lamontagne, J., Trujillo, M. E., et al. (2008) · Diabetes · doi:10.2337/db08-0540 · Cited by 65
Self-citationEvolutionary aspects of diet, essential fatty acids and cardiovascular disease
Simopoulos, A. P. (2001) · European Heart Journal Supplements · doi:10.1016/s1520-765x(01)90113-0 · Cited by 56
Thorseng, T., Witte, D. R., Vistisen, D., Borch-Johnsen, K., Bjerregaard, P., & Jørgensen, M. E. (2009) · International Journal of Circumpolar Health · doi:10.3402/ijch.v68i4.17373 · Cited by 42
Ji, S., Hardy, R. W., & Wood, P. A. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22179 · Cited by 33
Inflammation-Induced Insulin Resistance in Obesity When Immunity Affects Metabolic Control
White, P. J., & Marette, A. (2008) · Human Kinetics eBooks · doi:10.5040/9781492595748.ch-007 · Cited by 7
Self-citation
Cited by
Omega-3 polyunsaturated fatty acids and their health benefits
Shahidi, F., & Ambigaipalan, P. (2018) · Annual Review of Food Science and Technology · doi:10.1146/annurev-food-111317-095850 · Cited by 1,390
Impact of Obesity and Metabolic Syndrome on Immunity
Andersen, C. J., Murphy, K. E., & Fernandez, M. L. (2016) · Advances in Nutrition · doi:10.3945/an.115.010207 · Cited by 701
Domingueti, C. P., Dusse, L. M. S., Carvalho, M. D. G., de Sousa, L. P., Gomes, K. B., & Fernandes, A. P. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2015.12.018 · Cited by 647
Dalli, J., & Serhan, C. N. (2012) · Blood · doi:10.1182/blood-2012-04-423525 · Cited by 547
Oxidative stress and diabetes: antioxidative strategies
Zhang, P., Li, T., Wu, X., Nice, E. C., Huang, C., & Zhang, Y. (2020) · Frontiers of Medicine · doi:10.1007/s11684-019-0729-1 · Cited by 513
Metadata
- Authors
- White, P. J., Arita, M., Taguchi, R., Kang, J. X., & Marette, A.
- Affiliations
- Centre hospitalier universitaire de Québec (CA)
- The University of Tokyo (JP)
- Harvard University (US)
- Institut universitaire de cardiologie et de pneumologie de Québec (CA)
- Corresponding author
- Marette, André
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2010-09-14
- Volume
- 59
- Issue
- 12
- Pages
- 3066-3073
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC2992767
- OpenAlex
- W2098208341
- Cited by
- 185
- References
- 33
- Citations by year
- 2026: 4 · 2025: 2 · 2024: 8 · 2023: 10 · 2022: 10 · 2021: 14 · 2020: 13 · 2019: 9 · 2018: 11 · 2017: 14 · 2016: 15 · 2015: 13 · 2014: 21 · 2013: 18 · 2012: 15
- FWCI
- 12.44
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Japan Society for the Promotion of Science (21370051)
- National Cancer Institute (R01CA113605)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Keywords
- omega-3 fatty acids, inflammation resolution, protectin D1, docosanoids, obesity, insulin resistance, high-fat diet, adipose tissue macrophages, skeletal muscle, adipose tissue, inducible nitric oxide synthase, JNK, transgenic mice, chronic inflammation
- MeSH terms
- Animals, Dietary Fats, Fatty Acids, Inflammation, Insulin Resistance, Lipids, Male, Mice, Transgenic, Obesity, Tumor Necrosis Factor-alpha, Fatty Acids, Omega-3, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.